Spironolactone in Elderly Patients with HFpEF/HFmrEF: The SPIRIT-HF Study Suggests Caution

Medical news

This research, presented at ACC.26, investigated the efficacy of spironolactone compared to placebo in an elderly patient population diagnosed with heart failure with preserved (HFpEF) or mid-range (HFmrEF) ejection fraction.

Alexander Reed
Alexander Reed

Alexander Reed brings Cambridge's medical research scene to life through his insightful reporting. With a background in biochemistry and journalism, he excels at breaking down intricate scientific concepts for readers. His recent series on genomic medicine earned him the prestigious Medical Journalism Award.

Latest medical news online